Climb Bio Inc

Small-Cap Stocks Stocks Under $10 Biotech Stocks Healthcare Stocks

$6.78

+0.10 (+1.50%)

As of Mar 25, 3:06 PM ET ·

Analyst Consensus

Strong Buy

Analysts

Moderate

Coverage

Buy 12 92%

Hold 1 8%

Sell 0 0%

Price Target

Analyst Price Target +285.1% upside

Low Target $17.52

Average Target $26.11

High Target $31.20

Current Price $6.78

Current
$6.78

Target
$26.11

$17.52 $26.11 avg $31.20

Scenario Analysis

Bear Case

$17.52

158.4%

Low target

Base Case

$26.11

+285.1%

Avg target

Bull Case

$31.20

+360.2%

High target

Risk/Reward

2.3x

Favorable

Price in Context

52-Week High

$8.04

-15.7% from high

52-Week Low

$1.05

+545.7% from low

Target vs 52W High

$26.11

+224.8% vs high

Peer Consensus — Biotechnology

Stock	Consensus	Analysts	Buy %	Target	Upside
ABBV Abbvie Inc	Buy	39	69%	$257.58	+24.3%
AMGN Amgen Inc	Hold	42	50%	$190.87	-46.1%
GILD Gilead Sciences Inc	Strong Buy	37	81%	$362.68	+162.3%
VRTX Vertex Pharmaceuticals Inc	Strong Buy	39	79%	$438.34	-3.7%
REGN Regeneron Pharmaceuticals	Strong Buy	36	75%	$76.80	-89.8%
ALNY Alnylam Pharmaceuticals Inc	Strong Buy	36	78%	$102.31	-68.9%
INSM Insmed Inc	Strong Buy	26	92%	$143.40	-3.3%
NTRA Natera Inc	Strong Buy	27	89%	$142.91	-27.6%